Adetunji T Toriola
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adetunji T Toriola as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04067726 · RANKL Inhibition and Mammographic Breast DensityWashington University School of Medicine · active not recruiting · Dense Breasts · principal investigator
- Early Ph1NCT03629717 · RANKL Inhibition and Breast Tissue BiomarkersWashington University School of Medicine · completed · Breast Cancer Prevention, Mammographic Density · principal investigator
- N/ANCT02328677 · ColoCare Study - Colorectal Cancer CohortUniversity of Utah · recruiting · Colorectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 06 Prevention and Control ProgramP30CA091842 · NCI · WASHINGTON UNIVERSITY · fiscal years 2026 · $90,801 awarded in 2026Same name and institution; not confirmed by an ID
- Siteman Cancer Center Catchment CSRN ACCESS HubUG1CA286946 · NCI · WASHINGTON UNIVERSITY · fiscal years 2024 to 2026 · $874,688 awarded in 2026Same name and institution; not confirmed by an ID
- Surgical Oncology Basic Science and Translational Research Training ProgramT32CA009621 · NCI · WASHINGTON UNIVERSITY · fiscal years 2022 to 2026 · $251,600 awarded in 2026Same name and institution; not confirmed by an ID
- Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer PreventionR37CA235602 · NCI · WASHINGTON UNIVERSITY · fiscal years 2019 to 2025 · $599,882 awarded in 2025Grant number is on one of their registry trials
- Metabolite Profiles and Mammographic Density in Premenopausal WomenR01CA246592 · NCI · WASHINGTON UNIVERSITY · fiscal years 2020 to 2024 · $342,268 awarded in 2024Same name and institution; not confirmed by an ID
- RANK PATHWAY AND MAMMOGRAPHIC DENSITY IN MID-LIFE WOMENR21CA216515 · NCI · WASHINGTON UNIVERSITY · fiscal years 2017 to 2018 · $171,505 awarded in 2018Same name and institution; not confirmed by an ID
- EFFECT OF WEIGHT LOSS ON BONE HEALTH IN POSTMENOPAUSAL BREAST CANCER SURVIVORSR21CA161105 · NCI · WASHINGTON UNIVERSITY · fiscal years 2012 to 2013 · $160,127 awarded in 2013Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:59 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- 698 citationsRCR 20.6
- Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels.J Intern Med · 2013104 citationsRCR 3.7
- 52 citationsRCR 1.3
- Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.Pharmacogenet Genomics · 201316 citationsRCR 0.5
- Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.Breast Cancer Res Treat · 201514 citationsRCR 0.5
- 13 citationsRCR 0.5